Who owns TRISALUS LIFE SCIENCES INC?
- Ticker: TLSI
- CUSIP Number: 89680m101
Tip: Access positions for across all investors
Analyze quarterly positions in Trisalus Life Sciences with up to 7 years of data, all consolidated into one spreadsheet
Download as csv Download as ExcelTop investors of Trisalus Life Sciences stock
Who bought or sold TRISALUS LIFE SCIENCES INC this quarter?
Fund or Company Name | Shares Held | Valued At | Change in Shares | As Of | Actions |
---|---|---|---|---|---|
Wealthcare Advisory Partners | 644k | $3.0M | 100% | Sep 2024 |
|
Duquesne Family Office | 427k | $2.0M | 0% | Sep 2024 |
|
Vanguard Group | 416k | $2.3M | 149% | Jun 2024 |
|
Geode Capital Management | 200k | $924k | 45% | Sep 2024 |
|
Lido Advisors | 44k | $245k | 100% | Jun 2024 |
|
MSDC Management | 40k | $184k | 100% | Sep 2024 |
|
Exos Asset Management | 39k | $178M | -77% | Sep 2024 |
|
Connecticut Wealth Management | 33k | $152k | 0% | Sep 2024 |
|
BlackRock | 30k | $140k | 100% | Sep 2024 |
|
BlackRock | 30k | $167k | -28% | Jun 2024 |
|
Northern Trust | 26k | $121k | -8% | Sep 2024 |
|
Vestcor Investment Management Corp | 23k | $108k | 100% | Sep 2024 |
|
Goldman Sachs Group | 23k | $127k | -58% | Jun 2024 |
|
Angelo, Gordon & Co | 21k | $96k | 100% | Sep 2024 |
|
Virtu Financial | 20k | $92k | 100% | Sep 2024 |
|
Hrt Financial | 16k | $71k | -56% | Sep 2024 |
|
Cambridge Investment Research Advisors | 16k | $72k | 0% | Sep 2024 |
|
Magnetar Financial | 14k | $66k | 100% | Sep 2024 |
|
State Street Corporation | 11k | $61k | 100% | Jun 2024 |
|
Tower Research Capital | 5.9k | $33k | 284% | Jun 2024 |
|
Wolverine Asset Management | 4.7k | $22k | -89% | Sep 2024 |
|
Morgan Stanley | 2.0k | $11k | -85% | Jun 2024 |
|
Hoertkorn Richard Charles | 668.00 | $3.1k | 0% | Sep 2024 |
|
Bank of America Corporation | 148.00 | $681.998800 | 48% | Sep 2024 |
|
Signature | 100.00 | $461.000000 | 0% | Sep 2024 |
|
Jpmorgan Chase & Co | 25.00 | $115.000000 | 25% | Sep 2024 |
|
Wells Fargo & Company | 1.00 | $5.000000 | -100% | Sep 2024 |
|
Clear Street | 1.00 | $0 | 0% | Jun 2024 |
|
Who sold out of Trisalus Life Sciences?
Fund or Company Name | Date Sold | Shares Held | Valued At |
---|---|---|---|
Highbridge Capital Management | Jun 2024 | 215k | $1.2M |
Millennium Management | Jun 2024 | 123k | $678k |
Anson Capital | Jun 2024 | 24k | $135k |
Qube Research & Technologies | Mar 2024 | 5.5k | $54k |
Macquarie Group | Mar 2024 | 291.00 | $2.997300 |
GPS Wealth Strategies Group | Jun 2024 | 233.00 | $1.3k |
Deerfield Management Company | Jun 2024 | 1.00 | $6.000000 |